Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen Levels

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

2000 • 5,760 citations

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

1997 • 5,442 citations

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

1999 • 1,952 citations

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

1995 • 1,807 citations

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

2000 • 1,703 citations

Effect of Statin Therapy on C-Reactive Protein Levels

2001 • 1,627 citations

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

2001 • 1,537 citations

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

1999 • 1,488 citations

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

1998 • 1,398 citations

Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

1998 • 1,138 citations

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

1998 • 1,033 citations

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly

1997 • 838 citations

Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

2001 • 758 citations

Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study

1993 • 129 citations

Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia

1999 • 83 citations

The Effect of Atorvastatin on Serum Lipids, Lipoprotein(a) and Plasma Fibrinogen Levels in Primary Dyslipidaemia – A Pilot Study Involving Serial Sampling

2001 • 57 citations

Statin + fibrate combination therapy

1999 • 55 citations

Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study)

2000 • 52 citations

Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.

1998 • 46 citations

Treatment of Dyslipidaemias in Patients with Established Vascular Disease: A Revival of the Fibrates

2000 • 41 citations

Treatment of Dyslipidaemias in Patients with Established Vascular Disease: A Revival of the Fibrates

2000 • 28 citations

The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.

1990 • 27 citations

Do HMG-CoA Reductase Inhibitors Affect Fibrinogen?

2001 • 17 citations

The Effect of Atorvastatin on Serum Lipids, Lipoprotein(a) and Plasma Fibrinogen Levels in Primary Dyslipidaemia – A Pilot Study Involving Serial Sampling

2000 • 14 citations